Progestational agents prevent preterm birth induced by a nitric oxide synthesis inhibitor in the mouse

In Vivo. 2008 Jul-Aug;22(4):447-50.

Abstract

Background: The ability of the nitric oxide (NO) synthesis inhibitor NG-nitro-L-arginine methyl ester (L-NAME) to induce preterm parturition in the mouse has been previously documented. The present study tested the ability of progestational agents to prevent preterm birth induced by L-NAME.

Materials and methods: L-NAME was administered subcutaneously at 90 mg/kg on gestation day 16. Progesterone, medroxyprogesterone acetate and hydroxyprogesterone caproate were administered subcutaneously at 0 (vehicle), 5 or 10 mg/kg on gestation day 16 one hour before L-NAME and on day 17. Parturition was considered preterm if occurring before gestation day 18.

Results: Following treatment with L-NAME alone, 56.5% of the pregnant animals delivered before term. Treatment with progesterone, medroxyprogesterone acetate or hydroxyprogesterone caproate at 5 mg/kg or 10 mg/kg significantly and comparably reduced the rate of preterm birth caused by L-NAME.

Conclusion: Progestational agents are able to reduce preterm births induced by nitric oxide synthase (NOS) inhibition.

MeSH terms

  • 17 alpha-Hydroxyprogesterone Caproate
  • Animals
  • Enzyme Inhibitors / pharmacology*
  • Female
  • Hydroxyprogesterones / pharmacology
  • Medroxyprogesterone Acetate / pharmacology
  • Mice
  • Mice, Inbred ICR
  • NG-Nitroarginine Methyl Ester / pharmacology*
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Pregnancy
  • Pregnancy, Animal
  • Premature Birth / prevention & control
  • Progesterone / pharmacology
  • Progestins / pharmacology*

Substances

  • Enzyme Inhibitors
  • Hydroxyprogesterones
  • Progestins
  • 17 alpha-Hydroxyprogesterone Caproate
  • Nitric Oxide
  • Progesterone
  • Medroxyprogesterone Acetate
  • Nitric Oxide Synthase
  • NG-Nitroarginine Methyl Ester